AstraZeneca Stock Topples On Unexpected Breast Cancer Failure
· investors.com
AstraZeneca stock toppled in late trades Friday after the company's experimental breast cancer treatment failed to pass muster.
Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent?
8/27/2026 Amgen and AstraZeneca's drug, Tezspire, scored Thursday in an esophageal disease t...